Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena I Boshoff

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Nature Communications|November 2, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug developmentTiago Beites, Kathryn O'Brien, Divya Tiwari, et al.
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Identification and Evaluation of dibasic piperidines as novel cell wall inhibitors against <i>Mycobacterium tuberculosis</i>Claire Naylor, Gareth A Prosser, Tracy Bayliss, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
Nature Medicine|January 28, 2014
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug effluxRichard E Lee, Julian G Hurdle, Jiuyu Liu, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis TreatmentEric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Cell|November 3, 2018
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic DesignYin Yao Dong, Hua Wang, Ashley C W Pike, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
ACS Infectious Diseases|February 22, 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|November 2, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug developmentTiago Beites, Kathryn O'Brien, Divya Tiwari, et al.
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Identification and Evaluation of dibasic piperidines as novel cell wall inhibitors against <i>Mycobacterium tuberculosis</i>Claire Naylor, Gareth A Prosser, Tracy Bayliss, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
Nature Medicine|January 28, 2014
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug effluxRichard E Lee, Julian G Hurdle, Jiuyu Liu, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis TreatmentEric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Cell|November 3, 2018
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic DesignYin Yao Dong, Hua Wang, Ashley C W Pike, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
ACS Infectious Diseases|February 22, 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.
Pageof 10